New developments: chloroquine-resistance in Plasmodium falciparum

Warhurst, D; (2001) New developments: chloroquine-resistance in Plasmodium falciparum. Drug resistance updates, 4 (3). pp. 141-4. ISSN 1368-7646 DOI:

Full text not available from this repository. (Request a copy)


Chloroquine-resistance is associated with higher malaria mortality in children in Africa where the drug is still widely used. In sensitive strains the drug attacks hemoglobin digestion in the lysosome and prevents detoxification of hemin to hemozoin. Reduced drug uptake is responsible for resistance, which is incompletely associated with changes in lysosome membrane protein PGH1. The report discussed here gives evidence for the role of another lysosome membrane protein, PfCRT, where a change from lysine to threonine in a transmembrane domain determines the change to resistance. Other changes in PfCRT, and to some extent change(s) in PGH1, are believed to compensate for loss of fitness of the modified PfCRT.

Item Type: Article
Keywords: Animal, Antimalarials/pharmacology/therapeutic use, Chloroquine/pharmacology/*therapeutic use, *Drug Resistance/genetics, Human, Malaria, Falciparum/*drug therapy/genetics/metabolism, Animal, Antimalarials, pharmacology, therapeutic use, Chloroquine, pharmacology, therapeutic use, Drug Resistance, genetics, Human, Malaria, Falciparum, drug therapy, genetics, metabolism
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Pathogen Molecular Biology
Research Centre: Antimicrobial Resistance Centre (AMR)
Malaria Centre
PubMed ID: 11768327
Web of Science ID: 172315400001


Download activity - last 12 months
Downloads since deposit
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item